Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 23, 2018Molecular OncologyOpen Access

Molecular subtype classification of urothelial carcinoma in Lynch syndrome

View Full Paper
Ask AI
Bookmark
Share

Authors

CTChristina TherkildsenHvidovre HospitalPEPontus ErikssonLund UniversityMHMattias HöglundStatistics Sweden

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Therkildsen et al. (2018) studied this question.

synapsesocial.com/papers/6a6f2a008031ec7bb1dba01chttps://doi.org/10.1002/1878-0261.12325
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Comprehensive molecular characterization of urothelial bladder carcinoma2014 · 3,099 citations
  2. 2Universal Point of Care Testing for Lynch Syndrome in Patients with Upper Tract Urothelial Carcinoma2017 · 80 citations
  3. 3Molecular Analysis of Upper Tract and Bladder Urothelial Carcinoma: Results from a Microarray Comparison2015 · 43 citations
  4. 4Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial2016 · 3,768 citations
  5. 5Hereditary‐like urothelial carcinomas of the upper urinary tract benefit more from adjuvant cisplatin‐based chemotherapy after radical nephroureterectomy than do sporadic tumours2013 · 24 citations